Search Results - "MONTANA, OSCAR"

Impact of Gusty Northwesterly Winds on Biological Particles in Winter in Beijing by Yan, Wei-Zhuo, Wang, Bu-Ying, Oscar, Fajardo Montana, Jiang, Jing-Kun, Hao, Ji-Ming

“…Biological aerosol particles play a crucial role in cloud formation and succession of ecosystems and have a large impact on human health. However, the…”
Get more information

School Children’s exposure to 〖PM〗_(2.5) in a high pollution area of Bogotá, Colombia by Vargas-Legarda, Yisel Andrea, Toro-Martínez, Adriana Katherine, Rojas-Roa, Néstor Yesid, Fajardo-Montaña, Oscar A.

“…Approximately 93% of the world’s children under 15 are exposed to ambient PM2,5 levels exceeding the World Health Organization’s guidelines. PM2,5 and other…”
Get full text

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure by Teerlink, John R, Diaz, Rafael, Felker, G. Michael, McMurray, John J.V, Metra, Marco, Solomon, Scott D, Adams, Kirkwood F, Anand, Inder, Arias-Mendoza, Alexandra, Biering-Sørensen, Tor, Böhm, Michael, Bonderman, Diana, Cleland, John G.F, Corbalan, Ramon, Crespo-Leiro, Maria G, Dahlström, Ulf, Echeverria, Luis E, Fang, James C, Filippatos, Gerasimos, Fonseca, Cândida, Goncalvesova, Eva, Goudev, Assen R, Howlett, Jonathan G, Lanfear, David E, Li, Jing, Lund, Mayanna, Macdonald, Peter, Mareev, Viacheslav, Momomura, Shin-ichi, O’Meara, Eileen, Parkhomenko, Alexander, Ponikowski, Piotr, Ramires, Felix J.A, Serpytis, Pranas, Sliwa, Karen, Spinar, Jindrich, Suter, Thomas M, Tomcsanyi, Janos, Vandekerckhove, Hans, Vinereanu, Dragos, Voors, Adriaan A, Yilmaz, Mehmet B, Zannad, Faiez, Sharpsten, Lucie, Legg, Jason C, Varin, Claire, Honarpour, Narimon, Abbasi, Siddique A, Malik, Fady I, Kurtz, Christopher E

“…Among patients with heart failure and a reduced ejection fraction, those who received the cardiac myosin activator omecamtiv mecarbil had a lower incidence of…”
Get full text

P44 Spureous Systolic Hypertension or a Defined Arterial Stiffness Phenotype by Forcada, Pedro, Sangiovanni, Miguel, Pampinella, Wanda, Montaña, Oscar

“…Background High systolic blood pressure in young individuals with normal central pressure has been described as “Spureous Systolic Hypertension” and there is a…”
Get full text

P45 Comparison of Systemic and Regional Vascular Parameters Using New Ultrasound Techniques: Are they Clinically Useful? by Forcada, Pedro, Sangiovanni, Miguel, Pampinella, Wanda, Montaña, Oscar

“…Background US is a simple, reproducible and economic technique for vascular evaluation. New technologies using radiofrequency and multidimensional Doppler plus…”
Get full text

P176: Arterial Stiffness as A Part of A General Abnormality of the Fibrous Healing Process by Forcada, Pedro, Sangiovanni, Miguel, Camino, Alejandra, Pampinella, Wanda, Montaña, Oscar

“…Environment There seems to be a common abnormality of the healing process in several diseases as COPD, liver esteatosis, and arterial stiffening. Objective To…”
Get full text

Diseño de una silla de ruedas controlada por señales EEG para un paciente con parálisis cerebral by Jiménez, Cristian Camilo, Montaña, Oscar Rubiano, Castañeda, Angie Valencia, B, Rubén Hernández

“…La parálisis cerebral espástica es una enfermedad que abarca un gran porcentaje de la población infantil. Por lo tanto, el objetivo de este estudio es realizar…”
Get full text

Diseño de una silla de ruedas controlada por señales EEG para un paciente con parálisis cerebral by Jiménez, Cristian Camilo, Rubiano Montaña, Oscar, Valencia Castañeda, Angie, Hernández B., Rubén

Get full text

Monitoreo ambulatorio de presión arterial (mapa) y duración del efecto antihipertensivo: un estudio con una nueva forma farmacéutica de losartán de liberación sostenida (CRONOS) by Bendersky, Mario, Juncos, Luis, Waisman, Gabriel, Piskorz, Daniel, Santi, Ricardo López, Montaña, Oscar, Caruso, Gustavo, Koretzky, Martín, Gómez, Roberto

“…Antihypertensive drugs action should last at least 24 h in order to enhance adherence, with positive impact on CV morbimortality. ABPM allow us to evaluate…”
Get full text

Olimpíadas matemáticas: Una estrategia para el desarrollo del pensamiento matemático by Espinel Montaña, Oscar Andrés, Restrepo Becerra, Joaquín, Niño Rojas, Francisco

“…En este documento se presenta una descripción sobre el desarrollo de las primeras Olimpiadas Matemáticas de la Universidad de La Salle, estrategia orientada al…”
Get full text

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome by Batra, Gorav, Ghukasyan Lakic, Tatevik, Lindbäck, Johan, Held, Claes, White, Harvey D, Stewart, Ralph A H, Koenig, Wolfgang, Cannon, Christopher P, Budaj, Andrzej, Hagström, Emil, Siegbahn, Agneta, Wallentin, Lars

“…Inflammation promotes cardiovascular disease and anti-inflammatory treatment reduces cardiovascular events in patients with chronic coronary syndrome. Chronic…”
Get more information

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry by Lip, Gregory Y. H., Kotalczyk, Agnieszka, Teutsch, Christine, Diener, Hans-Christoph, Dubner, Sergio J., Halperin, Jonathan L., Ma, Chang-Sheng, Rothman, Kenneth J., Marler, Sabrina, Gurusamy, Venkatesh Kumar, Huisman, Menno V.

“…Background and purpose Prospectively collected data comparing the safety and effectiveness of individual non-vitamin K antagonists (NOACs) are lacking. Our…”
Get full text

Arterial stiffness as a part of a general abnormality of the fibrous healing process by Forcada, Pedro, Sangiovanni, Miguel, Camino, Alejandra, Pampinella, Wanda, Montaña, Oscar

Get full text

Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry by Lip, Gregory Y. H., Kotalczyk, Agnieszka, Teutsch, Christine, Diener, Hans-Christoph, Dubner, Sergio J., Halperin, Jonathan L., Ma, Chang-Sheng, Rothman, Kenneth J., Marler, Sabrina, Gurusamy, Venkatesh Kumar, Huisman, Menno V.

“…In this article, the name of the GLORIA-AF investigator Anastasios Kollias was given incorrectly as Athanasios Kollias in the Acknowledgements. The original…”
Get full text

1007 EVALUATION OF ANTIHYPERTENSIVE EFFECT WITH ABPM OF A NEW PHARMACEUTICAL FORM OF LOSARTAN by Bendersky, Mario, Juncos, Luis, Santi, Ricardo Lopez, Montaña, Oscar, Piskorz, Daniel, Waisman, Gabriel, Penna, María, Gómez, Roberto, Caruso, Gustavo, Koretzky, Martin

Get full text

Correlación clínico-radiológica de loops vasculares en el conducto auditivo interno con síntomas vestibulares by Rodríguez-Acosta, José F., Mercuri, Dafne C., Gómez-Rodríguez, Álvaro, Prieto-Terán, Jimmy E., Gómez-Hernández, Héctor I., Scherer, Matías E., Piedra, Ezequiel, Montaña, Óscar

Get full text

Abpm and duration of the antihypertensive effect: a study with a new formulation of sustained release losartan (CRONOS) by Bendersky, Mario, Juncos, Luis, Waisman, Gabriel Dario, Piskorz, Daniel, Lopez-Santi, Ricardo, Montaña, Oscar, Caruso, Gustavo, Kotetzky, Martin, Penna, Maria, Gomez, Roberto

“…Antihypertensive drugs action should last at least 24 h in order to enhance adherence, with positive impact on CV morbimortality. ABPM allow us to evaluate…”
Get more information

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction by Solomon, Scott D., McMurray, John J.V., Claggett, Brian, de Boer, Rudolf A., DeMets, David, Hernandez, Adrian F., Inzucchi, Silvio E., Kosiborod, Mikhail N., Lam, Carolyn S.P., Martinez, Felipe, Shah, Sanjiv J., Desai, Akshay S., Jhund, Pardeep S., Belohlavek, Jan, Chiang, Chern-En, Borleffs, C. Jan Willem, Comin-Colet, Josep, Dobreanu, Dan, Drozdz, Jaroslaw, Fang, James C., Alcocer-Gamba, Marco Antonio, Al Habeeb, Waleed, Han, Yaling, Cabrera Honorio, Jose Walter, Janssens, Stefan P., Katova, Tzvetana, Kitakaze, Masafumi, Merkely, Béla, O’Meara, Eileen, Saraiva, Jose Francisco Kerr, Tereshchenko, Sergey N., Thierer, Jorge, Vaduganathan, Muthiah, Vardeny, Orly, Verma, Subodh, Pham, Vinh Nguyen, Wilderäng, Ulrica, Zaozerska, Natalia, Bachus, Erasmus, Lindholm, Daniel, Petersson, Magnus, Langkilde, Anna Maria

“…In a trial involving patients with heart failure and a mildly reduced or preserved ejection fraction, dapagliflozin reduced the risk of worsening heart failure…”
Get full text

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial by Lakshmanan, Mark, Pais, Prem, Probstfield, Jeffrey, Riesmeyer, Jeffrey S, Keltai, Matyas, Cuello, Jose, Cuneo, Carlos, Cusimano, Sandra, Dominguez, Andrea, Fernandez, Alberto, Gallardo, Karina Beatriz, Lagrutta, Mariana, Romero Vidomlansky, Mariano, Sala, Jorgelina, Stival, Jorge, Virgillito, Luciana, Vogel, Daniel, Zucchiatti, Noemi, Hernandes, Mauro, Nakazone, Marcelo, Pizzato, Patricia, Reis, Heleno, Grigorova, Valentina, Aronson, Ronnie, Babin, Sandra, Bajaj, Harpreet, Berenbaum, Brian, Brault, Suzanne, Chandra, Prakash, Gauthier, Jean Sebastien, Houde, Ghislaine, Lochnan, Heather, Malik, Saleem, Mihailidis, John, Vecchiarelli, Jonathan, Aguirre, Maria Loreto, Lahsen, Rodolfo, Madrid, Claudia, Rodriguez, Jose F, Vidal Prada, Tatiana, Benesova, Radka, Kopeckova, Iva, Racicka, Eva, Szeghy Malicharova, Emilia, Zahumensky, Emil, Lier, Alexander, Schulze, Erik-Delf, Warken, Bernd, Balsay, Miklos, Birkus, Zita, Faludi, Peter, Peterfai, Eva, Reiber, István, Salamon, Csaba, Park, Sungha, Seung, Ki Bae, Mora, Lija, Avalos-Ramirez, Juan Antonio, Herrera-Marmolejo, Marisol, Parra Perez, Rosa Linda, Previn, Roopa, Villagordoa, Juan, Katzen, Colin, Rowe, David, Schmiedel, Ole, Czerwinski, Edward, Juzwiak-Czapiewska, Danuta, Nowacka, Elzbieta, Rozanska, Aleksandra, Doros, Rodica, Ferician Moza, Anca, Rosu, Mihaela, Vanghelie, Luminita, Zarnescu, Mihaela, Gelig, Ekaterina, Goryunova, Tatiana, Ilchenko, Roman, Khaykina, Elena, Shabelnikova, Olesya, Tsarkova, Olga, Swanepoel, Nicolaas, Venter, Esme, Cajas, Priscila, Garcia, Mar, Masmiquel, Luís, Ortega, Emilio, Terns, Manel, Vilaplana, Judith, Malmqvist, Lennart, Anderson, Robert, Barchini, George, Brautigam, Donald, Chakko, Simon, Charatz, Seth, Fitz-Patrick, David, Gillespie, Eve, Idriss, Soha, Lorber, Daniel, Ma, Siu-Ling, Wiegmann, Thomas

“…Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk…”
Get full text

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial by Lakshmanan, Mark, Pais, Prem, Probstfield, Jeffrey, Keltai, Matyas, Cuello, Jose, Cuneo, Carlos, Cusimano, Sandra, Dominguez, Andrea, Fernandez, Alberto, Gallardo, Karina Beatriz, Lagrutta, Mariana, Romero Vidomlansky, Mariano, Sala, Jorgelina, Stival, Jorge, Virgillito, Luciana, Vogel, Daniel, Zucchiatti, Noemi, Hernandes, Mauro, Nakazone, Marcelo, Pizzato, Patricia, Reis, Heleno, Grigorova, Valentina, Kurktschiev, Dimo, Aronson, Ronnie, Babin, Sandra, Bajaj, Harpreet, Berenbaum, Brian, Brault, Suzanne, Chandra, Prakash, Gauthier, Jean Sebastien, Houde, Ghislaine, Lochnan, Heather, Malik, Saleem, Mihailidis, John, Vecchiarelli, Jonathan, Aguirre, Maria Loreto, Lahsen, Rodolfo, Madrid, Claudia, Rodriguez, Jose F, Vidal Prada, Tatiana, Benesova, Radka, Kopeckova, Iva, Racicka, Eva, Szeghy Malicharova, Emilia, Zahumensky, Emil, Lier, Alexander, Schulze, Erik-Delf, Warken, Bernd, Balsay, Miklos, Birkus, Zita, Faludi, Peter, Peterfai, Eva, Reiber, István, Salamon, Csaba, Park, Sungha, Seung, Ki Bae, Mora, Lija, Avalos-Ramirez, Juan Antonio, Herrera-Marmolejo, Marisol, Parra Perez, Rosa Linda, Previn, Roopa, Villagordoa, Juan, Katzen, Colin, Rowe, David, Schmiedel, Ole, Czerwinski, Edward, Juzwiak-Czapiewska, Danuta, Nowacka, Elzbieta, Rozanska, Aleksandra, Doros, Rodica, Ferician Moza, Anca, Rosu, Mihaela, Vanghelie, Luminita, Zarnescu, Mihaela, Gelig, Ekaterina, Goryunova, Tatiana, Ilchenko, Roman, Khaykina, Elena, Shabelnikova, Olesya, Tsarkova, Olga, Swanepoel, Nicolaas, Venter, Esme, Cajas, Priscila, Garcia, Mar, Masmiquel, Luís, Ortega, Emilio, Terns, Manel, Vilaplana, Judith, Malmqvist, Lennart, Anderson, Robert, Barchini, George, Brautigam, Donald, Chakko, Simon, Charatz, Seth, Fitz-Patrick, David, Gillespie, Eve, Idriss, Soha, Lorber, Daniel, Ma, Siu-Ling, Wiegmann, Thomas

“…Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the…”
Get full text